Cisplatin and its analogues in the treatment of advanced breast cancer: a review
Open Access
- 1 June 1992
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (6) , 787-793
- https://doi.org/10.1038/bjc.1992.169
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1991
- Phase II study of carboplatin in advanced breast cancer: preliminary results.1991
- Cyclophosphamide, Adriamycin, and cis-Platinum (CAP) in Metastatic and Locally Advanced Breast CancerAmerican Journal of Clinical Oncology, 1988
- High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation studyEuropean Journal of Cancer and Clinical Oncology, 1987
- CARBOPLATIN - A VERY ACTIVE NEW CISPLATIN ANALOG IN THE TREATMENT OF SMALL CELL LUNG-CANCER1985
- Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancerCancer Chemotherapy and Pharmacology, 1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedulesAmerican Journal of Clinical Oncology, 1982
- High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.1980
- PHASE-II STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) IN ADVANCED BREAST-CANCER1978